Genscript Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	26,326	21,097	42,166	52,563	72,496	22,033
Market Cap Growth	16.15%	-49.97%	-19.78%	-27.50%	229.03%	-33.64%
Enterprise Value	23,308	18,906	38,022	47,670	64,744	14,836
Last Close Price	12.04	9.84	19.86	24.85	34.50	11.28
PE Ratio	1.08	0.92	-	-	-	-
Forward PE	45.30	-	-	-	-	-
PS Ratio	4.05	4.57	9.63	10.77	18.97	7.27
PB Ratio	0.76	0.63	2.64	4.95	6.70	3.48
P/TBV Ratio	0.76	0.63	3.94	6.85	9.25	3.30
P/FCF Ratio	26.12	-	-	-	-	-
P/OCF Ratio	14.68	35.90	-	-	-	-
PEG Ratio	-	2.52	2.52	2.52	2.52	2.52
EV/Sales Ratio	3.59	4.09	8.68	9.77	16.94	4.90
EV/EBITDA Ratio	160.33	34.75	58.29	-	-	-
EV/EBIT Ratio	-	262.23	185.81	-	-	-
EV/FCF Ratio	23.13	-	-	-	-	-
Debt / Equity Ratio	0.12	0.17	0.41	0.48	0.30	0.07
Debt / EBITDA Ratio	2.20	8.51	8.59	-	-	-
Debt / FCF Ratio	4.27	-	-	-	-	-
Asset Turnover	0.19	0.14	0.19	0.26	0.27	0.34
Inventory Turnover	8.23	7.64	5.12	6.17	5.46	5.60
Quick Ratio	1.78	2.46	4.50	2.99	3.80	2.85
Current Ratio	1.96	2.72	4.76	3.23	3.97	3.03
Return on Equity (ROE)	-1.94%	-5.46%	9.56%	-31.12%	-47.05%	-47.38%
Return on Assets (ROA)	2.56%	0.13%	0.55%	-11.45%	-12.88%	-10.94%
Return on Invested Capital (ROIC)	4.45%	0.34%	3.34%	-91.80%	-152.50%	-600.56%
Return on Capital Employed (ROCE)	3.70%	0.20%	0.90%	-21.90%	-20.80%	-18.30%
Earnings Yield	92.78%	109.05%	-1.77%	-3.36%	-3.86%	-7.21%
FCF Yield	3.83%	-4.42%	-9.99%	-4.99%	-2.90%	-9.61%
Buyback Yield / Dilution	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%
Total Shareholder Return	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.